BioEnsemble LLC
Dedicated to providing a comprehensive range of management consulting services to meet the strategic and tactical business needs of small and mid-size pharmaceutical, biotechnology and medical technology companies.
​​Our team has extensive experience in general management, business development, business  strategy, commercial, portfolio & life-cycle management, and fund raising & financing.
Dan Vickery, MBA, PhD Founder & President
Carolyn Myers, MBA, PhD Prinicipal

Dan is a pharmaceutical business development consultant with expertise in urology, immunology, CV, CNS and women's healthcare therapeutic areas, as well as expertise of special dosage forms and drug delivery. Dan is currently on the board of Urigen Pharmaceuticals and has held CEO, President, Chairman and managing consultants positions. He is an advisory board member of the Center for Molecular Medicine & Therapeutics and a board member of the Interstial Cystitis Association. He is a President's Circle member of the Ammerican Association for the Advancement of Science (AAAS) and a member of the Licensing Executive's Society (LES).

Prior to starting BioEnsemble, Dan held senior business development positions at Mylan, overseeing Mylan's branded products and drug delivery divisions, during which time he focused on transactions for drug delivery products in Europe, and in-licensing and out-licensing of branded products.

Prior to joining Mylan, Dan had world-wide commercial development responsibility at Pharmacia for the therapeutic areas of urology, women's healthcare and sexual dysfuntion.

Dan also has significant development experience, having lead the Regulatory Affairs department at Parke-Davis, a division of Warner-Lambert, during the time in which Lipitor was approved and launched.  
Carolyn Myers is an accomplished senior pharmaceutical executive with extensive experience creating, leading and growing health care businesses with a focus on delivering exceptional results.

Carolyn leverages her extensive industry and management expertise to advise C-Suite executives of small to mid-size pharma and biotech companies on a comprehensive range of strategic management, commercial and business development consulting services. She has led teams in formulating product, portfolio and commercial strategy, serving clients in R&D, commercial, and business development. Her product and portfolio strategy work spans the entire product lifecycle, from discovery to mature product strategy. Carolyn has operational experience with lab to launch and P&L responsibility having led several businesses in their operational and growth strategies serving as President Dey Laboratories, President Mylan Technologies, VP Global Alliance Management and International Business development at Allergan and VP Marketing at Forest Labs. She also has extensive sales & marketing experience from the numerous positions she held at Pharmacia. 

Carolyn earned a Ph.D. from the University of British Columbia and an MBA from Rutgers University.

Carolyn is a Steering Committee member of Mid Atlantic Bio Angels, a member of Golden Seeds, and a board member at the Centre for Molecular Medicine and Therapeutics.